Lung

CHMP Recommends Amivantamab Plus Chemo for Pretreated EGFR+ Superior NSCLC

The European Medicines Company’s Committee for Medicinal Merchandise for Human Use (CHMP) has advisable the approval of amivantamab-vmjw (Rybrevant) together with carboplatin and...

Dr Massarelli on Utilizing Selpercatinib and Pralsetinib in Treating Superior Non-Small Cell Lung Most cancers

Erminia Massarelli, MD, PhD, MS, co-director, Lung Most cancers and Thoracic Oncology Program, affiliate professor, Division of Medical Oncology & Therapeutics Analysis, Metropolis...

Dr Reckamp on Amivantamab in EGFR Exon 20–Mutated NSCLC

Karen L. Reckamp, MD, MS, professor of medication, director, Division of Medical Oncology and Lung Institute, Cedars-Sinai Medical Middle, affiliate director, Medical Analysis,...

Consultants Weigh in on Matter of Frontline Osimertinib Alone or With Chemo in EGFR-Mutant NSCLC

Jonathan W. Riess, MD, MSOn the twenty fifth Annual Worldwide Lung Most cancers Congress, Jonathan W. Riess, MD, MS, and James Chih-Hsin Yang...

Hot Topics